Patient-derived cell model screening service
Progress your lead agent to clinical candidate with confidence
predictTx Screen is Imagen’s unique Patient-Derived Cell (PDC) model screen that leverages the power of high-content imaging to provide key information on the cytotoxicity and chemotherapeutic potential of your agent early in the drug development process.
Why use predictTx Screen
- Test your target hypothesis
- Identify responder populations
- Investigate mechanism of action
- Validate efficacy and cytotoxicity
Benefit from:
- Cost efficient screening service compared to stand-alone studies
- Simple model selection from a panel of 50 well-characterised PDCs across more than 15 different solid tumour types
- Model characterisation data including NGS, patient treatment history, in vitro drug response to standard of care
- Proven predictive power over patient response in the clinic
- Fast data turnaround
- Scalable patient-derived models for dose escalation and repeat studies
- Amenable to small molecule and biotherapeutics screening